These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23485734)

  • 1. R132C IDH1 mutations are found in spindle cell hemangiomas and not in other vascular tumors or malformations.
    Kurek KC; Pansuriya TC; van Ruler MA; van den Akker B; Luks VL; Verbeke SL; Kozakewich HP; Sciot R; Lev D; Lazar AJ; Fletcher CD; Bovée JV
    Am J Pathol; 2013 May; 182(5):1494-500. PubMed ID: 23485734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis using Sanger and next generation sequencing in sporadic spindle cell hemangiomas: A study of 19 cases.
    Ten Broek RW; Bekers EM; de Leng WWJ; Strengman E; Tops BBJ; Kutzner H; Leeuwis JW; van Gorp JM; Creytens DH; Mentzel T; van Diest PJ; Eijkelenboom A; Flucke U
    Genes Chromosomes Cancer; 2017 Dec; 56(12):855-860. PubMed ID: 28845532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.
    Pansuriya TC; van Eijk R; d'Adamo P; van Ruler MA; Kuijjer ML; Oosting J; Cleton-Jansen AM; van Oosterwijk JG; Verbeke SL; Meijer D; van Wezel T; Nord KH; Sangiorgi L; Toker B; Liegl-Atzwanger B; San-Julian M; Sciot R; Limaye N; Kindblom LG; Daugaard S; Godfraind C; Boon LM; Vikkula M; Kurek KC; Szuhai K; French PJ; Bovée JV
    Nat Genet; 2011 Nov; 43(12):1256-61. PubMed ID: 22057234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spindle cell hemangioma: a clinicopathological and molecular analysis of eight cases].
    Hu X; Zou Y; Chen HJ; He X; Zhang HY
    Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):196-201. PubMed ID: 35249281
    [No Abstract]   [Full Text] [Related]  

  • 5. IDH1 R132C and ERC2 L309I Mutations Contribute to the Development of Maffucci's Syndrome.
    Cheng P; Chen K; Zhang S; Mu KT; Liang S; Zhang Y
    Front Endocrinol (Lausanne); 2021; 12():763349. PubMed ID: 34790172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDH1 immunohistochemistry reactivity and mosaic IDH1 or IDH2 somatic mutations in pediatric sporadic enchondroma and enchondromatosis.
    Saiji E; Pause FG; Lascombes P; Cerato Biderbost C; Marq NL; Berczy M; Merlini L; Rougemont AL
    Virchows Arch; 2019 Nov; 475(5):625-636. PubMed ID: 31240473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas.
    Mito JK; Bishop JA; Sadow PM; Stelow EB; Faquin WC; Mills SE; Krane JF; French CA; Fletcher CDM; Hornick JL; Sholl LM; Jo VY
    Am J Surg Pathol; 2018 Aug; 42(8):1067-1075. PubMed ID: 29683816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic
    Brown NJ; Ye Z; Stutterd C; Jayasinghe SI; Schneider A; Mullen S; Mandelstam SA; Hildebrand MS
    Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34588213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma.
    Catteau A; Girardi H; Monville F; Poggionovo C; Carpentier S; Frayssinet V; Voss J; Jenkins R; Boisselier B; Mokhtari K; Sanson M; Peyro-Saint-Paul H; Giannini C
    Acta Neuropathol Commun; 2014 Jun; 2():58. PubMed ID: 24889502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of Maffucci syndrome with a buccal hemangioma harboring a mutation in IDH1.
    Ichimura N; Yamamoto N; Toyama N; Hibi H
    Oral Oncol; 2021 Nov; 122():105553. PubMed ID: 34624834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2.
    Amary MF; Damato S; Halai D; Eskandarpour M; Berisha F; Bonar F; McCarthy S; Fantin VR; Straley KS; Lobo S; Aston W; Green CL; Gale RE; Tirabosco R; Futreal A; Campbell P; Presneau N; Flanagan AM
    Nat Genet; 2011 Nov; 43(12):1262-5. PubMed ID: 22057236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free DNA from plasma as a promising alternative for detection of gene mutations in patients with Maffucci syndrome.
    Sun Y; Fan X; Rao Y; Wang Z; Wang D; Yang X; Zheng L; Wen M; Cai R; Su L
    Hereditas; 2022 Jan; 159(1):4. PubMed ID: 35042566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.
    Chotirat S; Thongnoppakhun W; Promsuwicha O; Boonthimat C; Auewarakul CU
    J Hematol Oncol; 2012 Mar; 5():5. PubMed ID: 22397365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maffucci syndrome and neoplasms: a case report and review of the literature.
    Prokopchuk O; Andres S; Becker K; Holzapfel K; Hartmann D; Friess H
    BMC Res Notes; 2016 Feb; 9():126. PubMed ID: 26920730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic IDH1 mutation in a pituitary adenoma of a patient with Maffucci syndrome.
    Hao S; Hong CS; Feng J; Yang C; Chittiboina P; Zhang J; Zhuang Z
    J Neurosurg; 2016 Jun; 124(6):1562-7. PubMed ID: 26473790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.
    Amary MF; Bacsi K; Maggiani F; Damato S; Halai D; Berisha F; Pollock R; O'Donnell P; Grigoriadis A; Diss T; Eskandarpour M; Presneau N; Hogendoorn PC; Futreal A; Tirabosco R; Flanagan AM
    J Pathol; 2011 Jul; 224(3):334-43. PubMed ID: 21598255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a multi-specific monoclonal antibody MsMab-1 recognizing both IDH1 and IDH2 mutations.
    Kato Kaneko M; Ogasawara S; Kato Y
    Tohoku J Exp Med; 2013 Jun; 230(2):103-9. PubMed ID: 23782684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maffucci syndrome complicated by three different central nervous system tumors sharing an IDH1 R132C mutation: case report.
    Nejo T; Tanaka S; Ikemura M; Nomura M; Takayanagi S; Shin M; Ushiku T; Shibahara J; Saito N; Mukasa A
    J Neurosurg; 2019 Dec; 131(6):1829-1834. PubMed ID: 30579273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variants.
    Dogan S; Frosina D; Geronimo JA; Hernandez E; Mohanty A; Bale T; Hechtman JF; Arcila ME; Hameed MR; Jungbluth AA
    Hum Pathol; 2020 Dec; 106():45-53. PubMed ID: 33017591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent IDH1/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma.
    Arai M; Nobusawa S; Ikota H; Takemura S; Nakazato Y
    Brain Tumor Pathol; 2012 Oct; 29(4):201-6. PubMed ID: 22323113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.